Focus:
The myelofibrosis market is projected to increase from $545.2m last year to $1.02bn by 2025, according to a report by GlobalData.
The schizophrenia market is projected to increase from $6.4bn in 2015 to $7.3bn by 2025 at a compound annual growth rate of 1.4%, according to a report by GlobalData.
Developed nations expanding vaccination recommendations against seasonal influenza and growth of egg-based quadrivalent seasonal influenza vaccines are expected to increase growth of the seasonal influenza vaccine market, says a report...
